Pegasus Laboratories, Inc. FDA Inspection Record

FEI 1038896 · Inspections, Form 483s, warning letters and import refusals

Pegasus Laboratories, Inc. is an FDA-registered facility (FEI 1038896) located in Pensacola, FL, US. Registered operations: ANALYSIS; API MANUFACTURE; LABEL; MANUFACTURE. RegDataLab tracks 5 FDA inspections and 1 compliance action at this facility.

What FDA found at this site

Latest inspection
Jun 11, 2026: No Action Indicated (NAI)
Inspections on record
5 (1 VAI, 4 NAI)
Last OAI inspection
None on record
Warning letters
1 listed by FDA for this FEI, latest Aug 5, 2016
Recalls as the recalling firm
9, latest Jul 20, 2026

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Jun 11, 2026No Action Indicated (NAI)No citations listed
Feb 24, 2023Voluntary Action Indicated (VAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
Scientifically sound laboratory controls (21 CFR 211.160(b))
Calibration - at intervals, written program, remedial action (21 CFR 211.160(b)(4))
Written record of investigation incomplete (21 CFR 211.192)
Dec 22, 2016No Action Indicated (NAI)No citations listed
May 27, 2014No Action Indicated (NAI)No citations listed
Dec 8, 2011No Action Indicated (NAI)No citations listed

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Jul 20, 2026Class IIV-0183-2026Proin ER, phenylpropanolamine hydrochloride extended-release tablets, 145mg Tablets, Net…
Failed dissolution specifications
Sep 12, 2025Class IIV-0112-2025PROIN ER, (Phenylpropanolamine hydrochloride extended-release tablets), 145 mg, net…
An out of specification result was confirmed after data review in dissolution testing for Proin ER 145mg lot 25079A1 (ST10431 - 3 mo. @ CRT)…
Jun 24, 2025Class IIV-0102-2025Firocoxib Tablets for Horses, 57mg, 60 Tablets, Manufactured by: Pegasus Laboratories…
Out of specification result obtained for dissolution at 120 minutes.
Jan 20, 2025Class IIV-0058-2025Rebalance, Antiprotozoal Oral Suspension, sulfadiazine and pyrimethamine, Net Contents…
Due to a 3-month CRT stability failure for low Pyrimethamine Assay due to non-uniformity across the batch
Dec 29, 2023Class IIIV-0031-2024Proin ER" (phenylpropanolamine hydrochloride extended-release tablets) 145 mg
Due to multiple complaints (broken tablets) and a 3-month CRT stability failure for hardness.
Jun 9, 2023Class IIV-0140-2023Proin 50 mg (phenylpropanolamine hydrochloride) Chewable Tablets 50 mg per tablet… and 7 more products
Product stored at extreme temperatures during storage.
Oct 21, 2020Class IIV-0026-2021Proin ER (phenylpropanolamine hydrochloride extended-release tablets) 145 mg Manufactured…
Out of specification for microbial limits.
Jul 10, 2014Class IIV-167-2014ReBalance Antiprotozoal Oral Suspension (Sulfadiazine and Pyrimethamine For Oral Use in…
Low assay result for the Pyrimethamine at the 6-month stability time point.
May 24, 2012Class IIV-168-2012PROIN 75MG COUNT BOTTLES HAVE THE CORRECT BASE LABEL OF: "***PROIN 75 mg…
Pegasus Laboratories, Inc. is recalling 75 mg, 60 count bottles of Proin Lots 120416 and 120213 for misbranding. The affected product has…

FDA record score

23 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

10 records behind this number
RecordDatePoints x age weightAdds
Class II recall V-0183-2026, this FEI as the recalling firmJul 20, 20264 x 14
Class II recall V-0112-2025, this FEI as the recalling firmSep 12, 20254 x 14
Class II recall V-0102-2025, this FEI as the recalling firmJun 24, 20254 x 14
Class II recall V-0058-2025, this FEI as the recalling firmJan 20, 20254 x 14
Inspection classified VAIFeb 24, 20236 x 0.63.6
Class II recall V-0140-2023, this FEI as the recalling firmJun 9, 20234 x 0.62.4
Class II recall V-0026-2021, this FEI as the recalling firmOct 21, 20204 x 0.251
Warning letter on FDA's dashboard, which does not show close-outsAug 5, 201610 years or older, so it adds no points0
Class II recall V-167-2014, this FEI as the recalling firmJul 10, 201410 years or older, so it adds no points0
Class II recall V-168-2012, this FEI as the recalling firmMay 24, 201210 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 17, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 17, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 17, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 17, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 17, 2026Newest record Nov 16, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Pegasus Laboratories, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Pegasus Laboratories, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Pegasus Laboratories, Inc.
Location
Pensacola, FL (US)
Registration Expires
Dec 31, 2026
Operations
ANALYSIS; API MANUFACTURE; LABEL; MANUFACTURE
Source
decrs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.